Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorpromazine in resected stage III colon cancer
NCT05433402Phase 2Withdrawn
- Sponsor
- Sadat City University
- Start
- Jul 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Aminazin in colon cancer, sponsored by Sadat City University. Planned start Jul 2022; status: withdrawn.
02
Drugs
Aminazin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT05433402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05433402.